Keita Sasa

Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma

Satsuki Kishikawa, Takuo Hayashi, Tsuyoshi Saito et al. · Modern Pathology · 2020 · 37 citations · Full text

Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone

Kei Sano, Yoshiyuki Suehara, Taketo Okubo et al. · Journal of orthopaedic surgery · 2020 · 24 citations · Full text

Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas

Yoshiyuki Suehara, Shinji Kohsaka, Shigeo Yamaguchi et al. · Clinical Orthopaedics and Related Research · 2020 · 18 citations · Full text

Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma

Yoshiyuki Suehara, Shinji Kohsaka, Takuo Hayashi et al. · Clinical Orthopaedics and Related Research · 2020 · 15 citations · Full text

Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma

Atsushi Yamashita, Yoshiyuki Suehara, Takuo Hayashi et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2022 · 11 citations